Neuroleptic malignant syndrome (NMS): A rare presentation induced by an antiemetic - Case report

Psychiatria Danubina

Volumn 23, Issue SUPPL. 1, 2011, Pages

  Lal Kashyap, Gursharan ^a   Patel, Ashok G ^a  

^a South Essex Partnership University Foundation Trust ^*  (United Kingdom)

Author keywords

Antipsychotics; Hyoscine hydrobromide; Neuroleptic malignant syndrome; Schizophrenia

Indexed keywords

ANTIBIOTIC AGENT; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; CREATINE KINASE; DIAZEPAM; FLUPENTIXOL DECANOATE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; PROCYCLIDINE; QUETIAPINE; SCOPOLAMINE BROMIDE; VALPROATE SEMISODIUM;

ADULT; ANTIBIOTIC THERAPY; BEHAVIOR THERAPY; CASE REPORT; CONFERENCE PAPER; DETERIORATION; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECZEMA; ELECTROCONVULSIVE THERAPY; EVENING DOSAGE; HUMAN; HYPERSALIVATION; MALE; MENTAL HEALTH; NEUROLEPTIC MALIGNANT SYNDROME; PARANOID SCHIZOPHRENIA; PRESCRIPTION; PSYCHOTHERAPY; RELAPSE; SCHIZOPHRENIA; SIDE EFFECT;

ADULT; ANTIEMETICS; ANTIPSYCHOTIC AGENTS; HUMANS; MALE; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA, PARANOID; SCOPOLAMINE;

EID: 80052865938     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994; 739-42.
2. Balzan MV. The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity. Postgrad Med 1998; 74:72-6. (Pubitemid 28056906)
3. Benzer TI E medicine from webmd: Neuroleptic Malignant Syndrome Updated: Aug 18, 2009.
4. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993; 77:185-202. (Pubitemid 23066804)
5. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Psycho Pharmacol Bulletin 1988; 24:25-9.
6. Delay J, Pichot P, Lemperiere T, et al. [A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses]. Ann Med Psychol (Paris). 1960; 118:145-52.
7. Jahan MS, Farooque AI, Wahid Z. Neuroleptic malignant syndrome. J Natl Med Assoc 1992; 84:966-70.
8. Marino P, Sutin K. The ICU Book 3rd Ed. Lippincott Williams and Wilkins; Philadelphia: 2006.
9. Picard LS, Lindsay S, Strawn JR, Kaneria RM, Patel NC, Keck PE Jr. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations. Pharmacotherapy. Apr 2008; 28:530-5. (Pubitemid 351466464)
10. Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989; 146:717-25. (Pubitemid 19149581)
11. Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989; 50:18-25. (Pubitemid 19050611)
12. Stubner S, Rustenbeck E, Grohmann R, Wagner G, Engel R, Neundorfer G, Moller HJ, Hippius H, Ruther E: Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry 2004; 37(suppl 1):S54-S64. (Pubitemid 38658331)